Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dean B Evans
Low Residual Proliferation After Short-Term Letrozole Therapy Is an Early Predictive Marker of Response in High Proliferative ER-positive Breast Cancer
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Related publications
Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer
Oncology Letters
Cancer Research
Oncology
Proliferation, Steroid Receptors and Clinical/Pathological Response in Breast Cancer Treated With Letrozole
British Journal of Cancer
Cancer Research
Oncology
Short Term Increase in Risk of Breast Cancer After Full Term Pregnancy.
BMJ
Estrogen Therapy Induces an Unfolded Protein Response to Drive Cell Death in ER + Breast Cancer
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Is Letrozole Needed for Controlled Ovarian Stimulation in Patients With Estrogen Receptor-Positive Breast Cancer?
Gynecological Endocrinology
Gynecology
Endocrinology
Metabolism
Obstetrics
Diabetes
Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines
PLoS ONE
Multidisciplinary
Pictilisib Plus Anastrozole Reduces Proliferation in ER+ Breast Cancer
Cancer Discovery
Oncology
Accumulation of P53 Is Prognostic for Aromatase Inhibitor Resistance in Early-Stage Postmenopausal Patients With ER-positive Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Titration of Letrozole to Maintain Low Estradiol (E2) Levels During Fertility Preservation Cycles for Estrogen Receptor Positive (ER+) Breast Cancer Patients Does Not Impact Ovarian Response or Mature Oocyte Yield
Fertility and Sterility
Gynecology
Reproductive Medicine
Obstetrics
